Dolby Laboratories (DLB) FY2016 results: revenue $1.0 billion, up 5.7% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.0 billion for fiscal 2016, the year ended 30 September 2016, up 5.7% on the year before. Net income was $186 million, up 2.5%, and diluted earnings per share $1.81. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2016.
Revenue
$1.0 billion
+5.7% on the year
FY2009FY2016
Operating margin
22.6%
22.0% a year earlier
FY2009FY2016
Net income
$186 million
+2.5% on the year
FY2009FY2016
Diluted EPS
$1.81
+3.4% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
1,026
971
960
+5.7%
Cost of revenue
109
94.8
70.2
+14.9%
Gross profit
917
876
890
+4.7%
Gross margin
89.4%
90.2%
92.7%
Research and development
220
201
183
+9.1%
Operating income
232
213
274
+8.7%
Operating margin
22.6%
22.0%
28.5%
Interest expense
0.1
0.2
-0.2
-31.7%
Pre-tax income
236
246
276
-4.0%
Income tax
49.5
62.5
67.4
-20.8%
Effective tax rate
21.0%
25.4%
24.4%
Net income
186
181
206
+2.5%
Net margin
18.1%
18.7%
21.5%
Diluted EPS
$1.81
$1.75
$1.99
+3.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
360
309
362
+16.4%
Capital expenditure
101
158
75.4
-36.0%
Free cash flow
259
152
286
+70.8%
Free cash flow margin
25.3%
15.6%
29.8%
Cash from investing
-282
-204
-205
Cash from financing
-92.0
-139
-40.6
Depreciation and amortisation
85.2
69.1
53.3
+23.2%
Share-based compensation
67.0
67.1
65.7
-0.1%
Buybacks
101
107
56.0
-6.1%
Dividends paid
48.4
41.0
0.0
+18.0%
Dividend per share
$0.50
$0.42
$0.00
+19.0%
Diluted shares, weighted
102m
104m
104m
-1.4%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
1,970
1,807
1,710
+9.0%
Non-controlling interest
8.5
8.9
21.6
-5.1%
Debt
0.0
0.0
0.0
Other liabilities
331
317
252
+4.4%
Total liabilities and equity
2,310
2,133
1,984
+8.3%
Fixed assets
444
403
290
+10.1%
Goodwill
310
308
278
+0.6%
Intangible assets
215
128
63.7
+68.9%
Investments
516
460
528
+12.1%
Cash and equivalents
520
532
568
-2.3%
Receivables
75.7
102
86.2
-25.5%
Inventory
16.4
13.9
8.5
+17.9%
Other assets
214
188
162
+14.1%
Total assets
2,310
2,133
1,984
+8.3%
10-K for the year ended 30 September 2016, filed 18 November 2016: the filing.